VirginiaAmador

PhD Virginia Amador

Hospital Clínic de Barcelona

 

Contact

 
Carrer de Villarroel 170
08036 Barcelona
 
 

Studies

  • Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma
    Principal investigator: Elías Campo Güerri
    Funder: NATIONAL INSTITUT OF HEALTH (NHI)
    Code: 1P01CA229100
    Duration: 01/09/2019 - 31/08/2023
  • Tumor immune microenvironment in mantle cell lymphoma progression and control: characterization of critical immune factors and challenges for therapy (TIMSOX)
    Principal investigator: Virginia Amador Espinosa
    Funder: MINISTERIO DE CIENCIA, INNOVACIÓN Y UNIVERSIDADES (MCIU). PLAN ESTATAL 2018
    Code: RTI2018-099793-B-I00
    Duration: 01/01/2019 - 31/12/2021
  • Ayudas fundación científica AECC a personal investigador en cáncer
    Principal investigator: Virginia Amador Espinosa
    Funder: FUNDACIÓN ASOCIACIÓN ESPAÑOLA CONTRA EL CANCER (AECC) INVESTIGACIÓN CONTRA EL CÁNCER
    Duration: 10/10/2018 - 30/09/2022
  • Ajuts per a la contractació de personal investigador novell
    Principal investigator: Virginia Amador Espinosa
    Funder: AGENCIA DE GESTIÓ D’AJUTS UNIVERSITARIS I DE RECERCA (AGAUR), CATALUNYA
    Code: FI-DGR2018
    Duration: 01/01/2018 - 29/12/2020
  • Ayuda lanzadera de iniciación a la investigación en el área de Cáncer (CIBER), CIBERONC of cáncer 2016
    Principal investigator: Virginia Amador Espinosa
    Funder: AYUDA LANZADERA DE INICIACIÓN A LA INVESTIGACIÓN EN EL ÁREA DE
    ÁNCER (CIBER), CIBERONC DEL CÁNCER 2016
    Code: CIBERONC of cáncer 2016
    Duration: 01/09/2017 - 25/04/2018
 

Literature

Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia
Authors: Lee-Vergés E, Hanna BS, Yazdanparast H, Rodríguez V, Rodríguez ML, Giró A, Vidal-Crespo A, Rosich L, Amador V, Aymerich M, Villamor N, Delgado J, Lichter P, Pérez-Galán P, López-Guerra M, Campo E, Seiffert M, Colomer D.
Reference: INTERNATIONAL JOURNAL OF CANCER 2019; 144(11):2762-2773.

 

Increased Tumor Angiogenesis in SOX11-positive Mantle Cell Lymphoma
Authors: Petrakis G, Veloza L, Clot G, Gine E, Gonzalez-Farre B, Navarro A, Bea S, Martínez A, Lopez-Guillermo A, Amador V, Ribera-Cortada I, Campo E.
Reference: HISTOPATHOLOGY 2019; 75(5):704-714.

 

SOX11, a key oncogenic factor in mantle cell lymphoma.
Authors: Beekman R, Amador V, Campo E .
Reference: CURRENT OPINION IN HEMATOLOGY 2018; 25(4):299-306.

 
 
zurück zur Übersicht
Corporate Partners - Individual Sponsors
Wed, 16th September 2020 to Thu, 17th September 2020
Annual meeting of the European MCL Network
more dates
Tue, 23rd June 2020
The 1st Czernecki Donnelly Prize was awarded to Elisabeth Silkenstedt
more news